Search for: "Doe Entities 1-3" Results 581 - 600 of 10,117
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Oct 2023, 9:01 pm by News Desk
The Food and Drug Administration sends warning letters to entities under its jurisdiction as part of its enforcement activities. [read post]
26 Jan 2017, 8:15 am by Kirk Jenkins
Borrowing a test from the Open Meetings Act, the Court held that three factors determine whether an entity is a public entity for purposes of FOIA: (1) whether it has a legal existence independent of government resolution; (2) the nature of its functions; and (3) the degree of government control over it. [read post]
11 Aug 2014, 11:32 pm by Nietzer
This investigation has been going on for several years and there is no anticipated conclusion date at this time. 3. [read post]
1 Nov 2007, 7:21 am
For organizations faced with the challenges of addressing ESI, there are three crucial aspects about ESI needed to achieve eDiscovery readiness: (1) knowing the location, (2) understanding the availability or accessibility, and (3) understanding the potential relevance. [read post]
22 Mar 2017, 8:04 am by Steven Boutwell
On October 26, 2016, the SEC adopted final rules that (1) modernize Rule 147, (2) create a new Rule 147A, (3) amend Rule 504, and (4) repeal Rule 505 (collectively, the “Amendments”). [read post]
25 Jun 2020, 5:13 pm by John Jascob
Currently, smaller swaps entities are scheduled to come into compliance with certain margin requirements by September 1, 2021. [read post]
26 Jan 2015, 7:26 am by Loriann
In doing so, the majority clarified what section 2(d) protects: (1) The right to join with others and form associations; (2) The right to join with others in pursuit of other constitutional rights; and (3) The right to join with others on equal terms the power and strength of other groups. [read post]
2 Aug 2023, 7:08 am by Matthew Dochnal
How to Form a Holding Company: 3 Steps Here are the steps you need to follow to set-up a holding company: Step 1. [read post]
11 Mar 2019, 2:51 pm by tvasil
Example No. 3 (Valuation Cap) .In the above scenario, let’s assume that the Entity and the Investor also agree that there will be a $6,000,000 Valuation Cap. [read post]
6 Dec 2021, 6:24 am by Lisa Larrimore Ouellette
These costs to developers include (1) added complications and uncertainty for clinical trials process (such as those suggested by the FDA), (2) a potentially lower likelihood of being authorized or approved due to those complications, and (3) the substantial PR (and potential liability) risk if clinical trials result in harm to pregnant people. [read post]
First, is where a Chinese company does the development work for free or builds the product with its own technology as a base. [read post]
16 Feb 2009, 6:47 am
We had intended to have the series run until year-end, but only got to #6 before the IRS issued IRS Notice 2009-3 (see Plop plop, fizz fizz, oh what a 403(b) relief it is: IRS Notice 2009-3) that extended the plan document requirement to December 31, 2009. [read post]
16 Feb 2009, 6:47 am
We had intended to have the series run until year-end, but only got to #6 before the IRS issued IRS Notice 2009-3 (see Plop plop, fizz fizz, oh what a 403(b) relief it is: IRS Notice 2009-3) that extended the plan document requirement to December 31, 2009. [read post]